Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedSep 12, 2025
DataAggregated Company Financials
Companies7
  • 7D-2.8%
  • 3M-1.5%
  • 1Y-6.6%
  • YTD0.4%

Over the last 7 days, the Life Sciences industry has dropped 2.8%, driven by a pullback from Lonza Group of 3.4%. Overall the industry is down 6.6% in 12 months. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Sep 2025CHF 51.9bCHF 10.6bCHF 1.1b32.9x47.1x4.9x
Mon, 11 Aug 2025CHF 51.6bCHF 10.7bCHF 1.1b33.4x44.9x4.8x
Wed, 09 Jul 2025CHF 51.9bCHF 10.1bCHF 1.0b33.2x50x5.2x
Fri, 06 Jun 2025CHF 52.4bCHF 10.1bCHF 1.0b32x50.4x5.2x
Sun, 04 May 2025CHF 55.0bCHF 10.1bCHF 1.0b31.5x52.9x5.5x
Tue, 01 Apr 2025CHF 51.4bCHF 10.1bCHF 1.0b31.8x50.1x5.1x
Thu, 27 Feb 2025CHF 55.3bCHF 10.1bCHF 1.0b32.4x53.3x5.5x
Sat, 25 Jan 2025CHF 57.2bCHF 10.2bCHF 943.1m36.3x60.6x5.6x
Mon, 23 Dec 2024CHF 52.2bCHF 10.2bCHF 943.6m35.2x55.3x5.1x
Wed, 20 Nov 2024CHF 52.1bCHF 10.2bCHF 943.5m40.6x55.3x5.1x
Fri, 18 Oct 2024CHF 55.9bCHF 10.2bCHF 943.4m42.1x59.3x5.5x
Sun, 15 Sep 2024CHF 57.5bCHF 10.2bCHF 937.0m44.5x61.3x5.6x
Tue, 13 Aug 2024CHF 56.9bCHF 10.2bCHF 923.9m45.6x61.5x5.6x
Thu, 11 Jul 2024CHF 54.5bCHF 10.3bCHF 1.0b47x54.4x5.3x
Sat, 08 Jun 2024CHF 53.1bCHF 10.3bCHF 1.0b44x53x5.2x
Mon, 06 May 2024CHF 54.4bCHF 10.3bCHF 1.0b43.4x54.3x5.3x
Wed, 03 Apr 2024CHF 57.4bCHF 10.3bCHF 1.0b45.6x57.2x5.6x
Fri, 01 Mar 2024CHF 50.3bCHF 10.2bCHF 982.2m46.5x51.2x4.9x
Sun, 28 Jan 2024CHF 46.5bCHF 10.2bCHF 1.0b42.3x45.6x4.6x
Tue, 26 Dec 2023CHF 41.8bCHF 9.8bCHF 1.5b32.4x28x4.3x
Thu, 23 Nov 2023CHF 41.4bCHF 9.8bCHF 1.5b29.8x27.7x4.2x
Sat, 21 Oct 2023CHF 38.3bCHF 9.8bCHF 1.5b26.9x25.7x3.9x
Mon, 18 Sep 2023CHF 52.6bCHF 9.8bCHF 1.5b35.4x35.3x5.4x
Wed, 16 Aug 2023CHF 53.1bCHF 9.8bCHF 1.5b38.3x34.3x5.4x
Fri, 14 Jul 2023CHF 55.4bCHF 9.7bCHF 1.6b36.4x33.9x5.7x
Sun, 11 Jun 2023CHF 58.7bCHF 9.7bCHF 1.6b37x35.9x6.1x
Tue, 09 May 2023CHF 61.7bCHF 9.7bCHF 1.6b40.4x37.7x6.4x
Thu, 06 Apr 2023CHF 58.4bCHF 9.7bCHF 1.7b41.4x35x6x
Sat, 04 Mar 2023CHF 59.9bCHF 9.6bCHF 1.7b34.6x36x6.3x
Mon, 30 Jan 2023CHF 56.2bCHF 9.6bCHF 1.6b32.4x34.4x5.9x
Wed, 28 Dec 2022CHF 49.7bCHF 9.2bCHF 1.3b36.9x37.4x5.4x
Fri, 25 Nov 2022CHF 55.3bCHF 9.2bCHF 1.3b41.4x41.6x6x
Sun, 23 Oct 2022CHF 51.5bCHF 9.2bCHF 1.3b40.2x38.7x5.6x
Tue, 20 Sep 2022CHF 48.7bCHF 9.2bCHF 1.3b38.1x37.6x5.3x
Price to Earnings Ratio

37.6x


Total Market Cap: CHF 48.7bTotal Earnings: CHF 1.3bTotal Revenue: CHF 9.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 45x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 45.0x.
  • The industry is trading close to its 3-year average PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 5.2% per year over the last three years.
  • Meanwhile revenues for these companies have grown 5.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.29%
Healthcare-1.85%
Life Sciences-2.80%
Clinical Research and Equipment-2.80%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SFZN Siegfried HoldingCHF 86.301.5%
+CHF 56.9m		-26.6%PE24.5x
XLS Xlife SciencesCHF 21.402.9%
+CHF 3.5m		-25.2%PE3.6x

Latest News

SFZN
CHF 86.30
Siegfried Holding
7D
1.5%
1Y
-26.6%

Pharmaceutical Outsourcing And Supply Chain Resilience Will Drive Future Expansion

Siegfried Holding’s consensus analyst price target saw a marginal decrease to CHF110.67, as both revenue growth forecasts and discount rate assumptions remained effectively unchanged. What's in the News Siegfried Holding expects sales growth in the mid-single-digit percentage range in local currencies for 2025.
LONN
CHF 547.60
Lonza Group
7D
-5.2%
1Y
-1.3%

What Is Lonza Group AG's (VTX:LONN) Share Price Doing?

Sep 10
What Is Lonza Group AG's (VTX:LONN) Share Price Doing?
TECN
CHF 155.90
Tecan Group
7D
-0.3%
1Y
-44.2%

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.
SKAN
CHF 57.40
SKAN Group
7D
-1.5%
1Y
-29.3%

US And Asian Expansion Will Unlock Pharmaceutical Market Potential

With no changes in key valuation metrics such as the discount rate (4.16%) and future P/E (28.70x), SKAN Group’s consensus analyst price target remains unchanged at CHF84.00. What's in the News SKAN Group AG confirmed its full-year 2025 earnings guidance, targeting sales growth in the mid-teens.
PPGN
CHF 24.60
PolyPeptide Group
7D
-5.4%
1Y
-27.1%
BANB
CHF 61.45
Bachem Holding
7D
-3.4%
1Y
-18.8%

Bachem Holding (VTX:BANB) Seems To Use Debt Quite Sensibly

Aug 16
Bachem Holding (VTX:BANB) Seems To Use Debt Quite Sensibly
XLS
CHF 21.40
Xlife Sciences
7D
2.9%
1Y
-25.2%